Richard T. Penson, MD, MRCP
Clinical Director Medical Oncology Group
Massachusetts General Hospital/Harvard University
55 Fruit Street, Yawkey Center, Suite 9E
Boston,
MA
USA
02114
Papers:
139 - Scientific Plenary
Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262
143 - Scientific Plenary
Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: a Gynecologic Oncology Group (GOG) study
144 - Scientific Plenary
High-risk patients with recurrent/advanced cervical cancer may derive the most benefit from antiangiogenesis therapy: a Gynecologic Oncology Group (GOG) study